Compuestos derivados de n-(1h-indazol-4-il)imidazo[1,2-a]piridin-3-carboxamida, inhbidores de la tirosina quinasa receptora de tipo iii; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades inflamatorias, cardiovasculares, fibrosis, trastornos autoinmunes, dolor, quemaduras

and pharmaceutically acceptable salts thereof in which R1, R2, R3, R4, R5 and R6 have the meanings given in the specification, are inhibitors of cFMS and are useful in the treatment of fibrosis, bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases, pain...

Full description

Saved in:
Bibliographic Details
Main Authors FREDRIK P. MARMSATER, ERIK JAMES HICKEN, DAVID A. MARESKA, MARTHA E. RODRIGUEZ, APRIL L. KENNEDY, BRYSON RAST, BRAD NEWHOUSE, QIAN ZHAO, ROBERT KIRK DELISLE, JAMES P. RIZZI, MARK C. MUNSON, MARK LAURENCE BOYS, GEORGE T. TOPALOV
Format Patent
LanguageSpanish
Published 06.12.2013
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract and pharmaceutically acceptable salts thereof in which R1, R2, R3, R4, R5 and R6 have the meanings given in the specification, are inhibitors of cFMS and are useful in the treatment of fibrosis, bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases, pain and burns in a mammal.
AbstractList and pharmaceutically acceptable salts thereof in which R1, R2, R3, R4, R5 and R6 have the meanings given in the specification, are inhibitors of cFMS and are useful in the treatment of fibrosis, bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases, pain and burns in a mammal.
Author MARK C. MUNSON
JAMES P. RIZZI
GEORGE T. TOPALOV
BRAD NEWHOUSE
APRIL L. KENNEDY
QIAN ZHAO
BRYSON RAST
ERIK JAMES HICKEN
FREDRIK P. MARMSATER
MARK LAURENCE BOYS
ROBERT KIRK DELISLE
MARTHA E. RODRIGUEZ
DAVID A. MARESKA
Author_xml – fullname: FREDRIK P. MARMSATER
– fullname: ERIK JAMES HICKEN
– fullname: DAVID A. MARESKA
– fullname: MARTHA E. RODRIGUEZ
– fullname: APRIL L. KENNEDY
– fullname: BRYSON RAST
– fullname: BRAD NEWHOUSE
– fullname: QIAN ZHAO
– fullname: ROBERT KIRK DELISLE
– fullname: JAMES P. RIZZI
– fullname: MARK C. MUNSON
– fullname: MARK LAURENCE BOYS
– fullname: GEORGE T. TOPALOV
BookMark eNqNkM9KAzEQhyvoQa3vMOBFYQPdVuihJymKB4_eRMo0maUD2ZmYP0V9emeLD-AlmUk-fvkyV7NzUaHLs_VWx9SoVC0QKPMRw6kCcXf9wbEE_NHoHhzHex556t77bunwI3HmwOJWzmPe6xdOtx2wHPYcNNMpJSJUzlpYED6brQUhk6dUNeMEVE4KzLyBlNVT0ekwZUqY0bPKBrwJWsDUwIB5RE-tsscNfEMzngQoQs1YzYCknhJIBsojBQzmwTJEHNGeZCwdmG5gPWLxLaJ5djDwfnK0ymJsFFlsBtiqsoxNJiJo1NzZF2jE0Ayazy4GjIVu_vbr2e3z09v2xVHSHZVklkJ1t31dLvrVYtGv--Vjv_of9QtfIY6_
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID CL2013001712A1
GroupedDBID EVB
ID FETCH-epo_espacenet_CL2013001712A13
IEDL.DBID EVB
IngestDate Fri Jul 19 15:23:43 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Spanish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CL2013001712A13
Notes Application Number: CL20130001712
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131206&DB=EPODOC&CC=CL&NR=2013001712A1
ParticipantIDs epo_espacenet_CL2013001712A1
PublicationCentury 2000
PublicationDate 20131206
PublicationDateYYYYMMDD 2013-12-06
PublicationDate_xml – month: 12
  year: 2013
  text: 20131206
  day: 06
PublicationDecade 2010
PublicationYear 2013
RelatedCompanies ARRAY BIOPHARMA INC
RelatedCompanies_xml – name: ARRAY BIOPHARMA INC
Score 2.7847617
Snippet and pharmaceutically acceptable salts thereof in which R1, R2, R3, R4, R5 and R6 have the meanings given in the specification, are inhibitors of cFMS and are...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Compuestos derivados de n-(1h-indazol-4-il)imidazo[1,2-a]piridin-3-carboxamida, inhbidores de la tirosina quinasa receptora de tipo iii; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades inflamatorias, cardiovasculares, fibrosis, trastornos autoinmunes, dolor, quemaduras
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131206&DB=EPODOC&locale=&CC=CL&NR=2013001712A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3ra9RAEF9LFes3rYqtVRaUQ-GC3VwuuXIcYnN3FOkLqVIQKbvJhi7kdtM8fPSv72-Wq55f-iXZF5N9zO48MjvD2FsFxB0KcnS7F0FAGe0OAxXHFDV1kIxEMQJPQRecj47jg6_R5_Ph-Rorb-_CeD-hv7xzROyoDPu99ed19U-JNfW2lc0HZVDkPs7PJtPeUjoWAxHuxr3p_mR2ejI9SXtpOkkPe8dffJ33DRN-gqx0H4x0Qvth9m2f7qVUq0Rl_pg9OAU82z5ha7rZZBvpbey1TfbwaPnLG8nl7mue3kt8CAYKBdPwHJjzU-Y-xW3wTlwGJF1fuzKIAlO-NwtDue-iHwbyR2VqAyIVDIJM1sr9llTb58ZeKkOhRjyUUvLWgGgaK_lVh2cjOc5DXUEsl9SgNZXjxpgx92SvcVRY1Zrch2eYsjEnA3VHmhJnebGiLB_zP7xDe225Ljk5xEUPMHQPQdOdQxBlmaMfQHjgKGkCjGz6PPvPXFajpIB8j08gBTBk2mkxB7JrnbGLzlKLHOd53ccQ9ELmHRo9Y2_ms7P0IMAKXPxd8Iv0cHW5Bs_ZunVWv2BcCZWBX0wSvCMRxnIvK5TIorzIszAbyS22cxek7burX7JHlPXGKvEOW2_rTr8Cy9Gq1x5TbgBHwOGt
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFDbThhhvbIBgG2AJVIHUiCVNk05VhVjaqkDbTaigSQhVduJollIn5AIbv57vWB2Ul70kjm2d2PGxzyXnwtgrCcTtuhTo9sSHgNI77joyCChraifsuWkPPAU5OM_mweSL__Gie7HFshtfGBsn9JcNjogdFWO_1_a8Lv4psYbWtrJ6KzWq8nfjxWDYWkvHbsf1joPW8HQwOj8bnkWtKBpE09b8s22zsWG895CVdsBkh7QfRl9PyS-l2CQq4wfs7jngmXqPbalqn-1GN7nX9tm92fqXN4rr3Vc9vBPaFAyUCqbiCTDnp0hsiRvntXvpkHT9O88c39HZG73S9PTNbXuO-F7oUoNIOR0nFqXMrwS1trk2l1JTqhELJRO81iCa2gj-o8G1EhznoSoglgvqUOsi51rrPrdkr8qpsigVhQ-P8cn6nAzUc9KU5IanG8ryPr_mDforw1XGKSAuRoCpWwiKfA5BlEWCcQDhgaOkCdCiavP4P3NZhZoU8j1egRLAkGmnwTcQTZ1rs2oM9UhwnpdtTEGtRNKg0yP2cjxaRBMHK7D8u-DLaLq5XJ3HbNvkRj1hXLoyBr8Yhrj7rheIkziVbuwnaRJ7cU88ZUe3QTq4vfkF250sZtPl9MP80yG7T03WcCU4Ytt12ahnYD9q-dxizR8RleSg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Compuestos+derivados+de+n-%281h-indazol-4-il%29imidazo%5B1%2C2-a%5Dpiridin-3-carboxamida%2C+inhbidores+de+la+tirosina+quinasa+receptora+de+tipo+iii%3B+proceso+de+preparacion%3B+composicion+farmaceutica%3B+y+uso+en+el+tratamiento+de+enfermedades+inflamatorias%2C+cardiovasculares%2C+fibrosis%2C+trastornos+autoinmunes%2C+dolor%2C+quemaduras&rft.inventor=FREDRIK+P.+MARMSATER&rft.inventor=ERIK+JAMES+HICKEN&rft.inventor=DAVID+A.+MARESKA&rft.inventor=MARTHA+E.+RODRIGUEZ&rft.inventor=APRIL+L.+KENNEDY&rft.inventor=BRYSON+RAST&rft.inventor=BRAD+NEWHOUSE&rft.inventor=QIAN+ZHAO&rft.inventor=ROBERT+KIRK+DELISLE&rft.inventor=JAMES+P.+RIZZI&rft.inventor=MARK+C.+MUNSON&rft.inventor=MARK+LAURENCE+BOYS&rft.inventor=GEORGE+T.+TOPALOV&rft.date=2013-12-06&rft.externalDBID=A1&rft.externalDocID=CL2013001712A1